Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature

Leukemia Research

Volumn 36, Issue 1, 2012, Pages 72-80

  Mathew, Rahel A ^a,b   Bennett, John M ^c   Liu, Jane Jijun ^b   Komrokji, Rami S ^b   Lancet, Jeffrey E ^b   Naghashpour, Mojdeh ^b   Messina, Jane L ^a,b   List, Alan F ^b   Moscinski, Lynn C ^b   Zhang, Ling ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Chronic myelomonocytic leukemia; Cutaneous manifestation; Leukemia cutis; Prediction of prognosis

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; AZACITIDINE; BORTEZOMIB; CD123 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CLADRIBINE; CPX 351; CYTARABINE; DACOGON; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IMATINIB; LEUKOSIALIN; MINOCYCLINE; MITOXANTRONE; PREDNISONE; RAZOXANE; STEM CELL FACTOR RECEPTOR; TIOGUANINE; TRICIRIBINE; UNCLASSIFIED DRUG; ZARMESTRA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER GROWTH; CANCER SURVIVAL; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; ERYTHEMA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; KARYOTYPE; LEUKOCYTE COUNT; LOW DRUG DOSE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; METAPHASE; MONOCYTE; OVERALL SURVIVAL; PLAQUE FORMING CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN BIOPSY; SKIN LEUKEMIA; SKIN MANIFESTATION; SKIN NODULE; SPLENOMEGALY;

ACCELERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 83555173389     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.05.003     Document Type: Article

References (33)

1. Orazi A., Bennett J.M., Germing U., Brunning R.D., Bain B.J., Thiele J. Chronic myelomonocytic leukemia. WHO classification of tumours of haematopoietic and lymphoid Tissues 2008, 76-81. IARC, Lyon, France. S.H. Swerdlow (Ed.).
2. George T.I. Pathology of the myeloproliferative diseases. Wintrobe's clinical hematopathy 2009, vol. 2:1988-1989. Wolters Kluwer/Lippincott Williams & Wilkins.
3. Hee Cho-Vega J., Medeiros L.J., Prieto V.G., Vega F. Leukemia cutis. Am J Clin Pathol 2008, 129:130-142.
4. Weedon D. Cutaneous infiltrates: lymphomatous and leukemic. Skin pathology 2002, Churchill Livingstone, New York, NY, p. 1118-20. 2nd ed.
5. McCollum A., Bigelow C.L., Elkins S.L., Hardy C.L., Files J.C. Unusual skin lesions in chronic myelomonocytic leukemia. South Med J 2003, 96(7):681-684.
6. Su W.P., Buechner S.A., Li C.Y. Clinicopathologic correlations in leukemia cutis. J Am Acad Dermatol 1984, 11:121-128.
7. Watson K.M., Mufti G., Salisbury J.R., et al. Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukaemia cutis. Clin Exp Dermatol 2006, 31:218-221.
8. Desch J.K., Smoller B.R. The spectrum of cutaneous disease in leukemias. J Cutan Pathol 1993, 20(5):407-410.
9. Hussein M.R., Al bshabshe A.A., Dalati T. Leukemia cutis: case report and review of literature. Appl Immunohistochem Mol Morphol 2010, 18(2):190-191.
10. Avivi I., Rosenbaum H., Levy Y., Rowe J. Myelodysplastic syndrome and associated skin lesions: a review of the literature. Leuk Res 1999, 23(4):323-330.
11. Braga D., Manganoni A.M., Boccaletti V., Pancera C., Marocolo D., Facchetti F., De Panfilis G. Specific skin infiltration as first sign of chronic myelomonocytic leukemia with an unusual phenotype. J Am Acad Dermatol 1996, 35(5 Pt 2):804-807.
12. Copplestone J.A., Oscier D.G., Mufti G.J., Hamblin T.J. Monocytic skin infiltration in chronic myelomonocytic leukaemia. Clin Lab Haematol 1986, 8(2):115-119.
13. Duguid J.K.M., Mackie M.J., McVerry B.A. Skin infiltration associated with CMML. Br J Hematol 1983, 53:257-264.
14. Dyachenko P., Rozenman D., Bennett M. Unusual skin and testicular lesions in a patient with CMML. Eur J Int Med 2006, 17:290-291.
15. Eubanks S.W., Patterson J.W. Subacute myelomonocytic leukemia-an unusual skin manifestation. J Am Acad Dermatol 1983, 9:581-584.
16. Horiuchi Y., Masuzawa M., Nozaki O., Shibahara N., Shiga T., Yoshida M. Unusual cutaneous lesions associated with chronic myelomonocytic leukaemia. Clin Exp Dermatol 1992, 17(2):121-124.
17. Longacre T.A., Smoller B.R. Leukemia cutis. Analysis of 50 biopsy-proven cases with an emphasis on occurrence in myelodysplastic syndromes. Am J Clin Pathol 1993, 100(3):276-284.
18. Mahmood S., Cooper A., Ireland R., Pocock C. Leukaemia cutis with chronic myelomonocytic leukaemia. Br J Haematol 2009, 147(4):413.
19. Pozo-Román T., Javier Menárguez-Palanca F., Gómez-Pineda A., González-Herrada C.M., Lázaro-Ochaita P. Specific cutaneous involvement in the course of chronic myelomonocytic leukemia simultaneously with blastic leukemic transformation. Report of a case with histologic and cytochemical study. J Am Acad Dermatol 1985, 12(5 Pt 2):943-948.
20. Yavorkovsky L. Monocytic leukemia cutis diagnosed simultaneously with refractory anemia with monocytosis: a case report. Am J Hematol 2001, 66:120-122.
21. Kaune K.M., Baumgart M., Bertsch H.P., Mitteldorf C., Müller-Hermelink H.K., Haase D., Ghadimi B.M., Schön M.P., Neumann C. Solitary cutaneous nodule of blastic plasmacytoid dendritic cell neoplasm progressing to overt leukemia cutis after chemotherapy: immunohistology and FISH analysis confirmed the diagnosis. Am J Dermatopathol 2009, 31(7):695-701.
22. Löffler H., Kosely F., Ho A.D., Krämer A. Blastic plasmacytoid dendritic cell neoplasm: a rare differential diagnosis of neoplastic skin infiltrations associated with systemic symptoms. Dtsch Med Wochenschr 2009, 134(39):1927-1930.
23. Magro C.M., Porcu P., Schaefer J., Erter J.W., Furman R.R., Shitabata P.K., Crowson A.N. Cutaneous CD4+ CD56+ hematologic malignancies. J Am Acad Dermatol 2010, 63(2):292-308.
24. Fett N., Liu R.H. Multicentric reticulohistiocytosis with dermatomyositis-like features: a more common disease presentation than previously thought. Dermatology 2011, (January). [Epub ahead of print].
25. Tan B.H., Barry C.I., Wick M.R., White K.P., Brown J.G., Lee A., Litchfield A.H., Lener E.V., Shitabata P.K. Multicentric reticulohistiocytosis and urologic carcinomas: a possible paraneoplastic association. J Cutan Pathol 2011, 38(1):43-48.
26. Germing U., Kündgen A., Gattermann N. Risk assessment in chronic myelomonocytic leukemia (CMML). Leuk Lymphoma 2004, 45(7):1311-1318.
27. Cota C., Vale E., Viana I., Requena L., Ferrara G., Anemona L., Metze D., Fink-Puches R., Wiesner T., Cerroni L. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol 2010, 34(1):75-87.
28. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., et al. WHO classification of tumours of haematopoietics and lymphoid tissues 2008, IARC Press, Lyon France, p. 145-7. 4th ed.
29. Bénet C., Gomez A., Aguilar C., Delattre C., Vergier B., Beylot-Barry M., et al. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases. Am J Clin Pathol 2011, 135(February (2)):278-290.
30. Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005, 105:3768-3785.
31. Dalle S., Beylot-Barry M., Bagot M., Lipsker D., Machet L., Joly P., et al. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?. Br J Dermatol 2010, 162:74-79.
32. Levine D., Miller S., Al-Dawsari N., Barak O., Gottlieb A.B. Paraneoplastic dermatoses associated with gynecologic and breast malignancies. Obstet Gynecol Surv 2010, 65(7):455-461.
33. Such E., Cervera J., Costa D., Solé F., Vallespì T., Luño E., et al. Cytogenetic risk stratification in chronic myelomonocytic leukemia. Haematologica 2011, 96(March (3)):375-383.